My Portfolio - New Portfolio
BNZ2020
My PortfolioIndividual Investor
Ranked #444,244 out of 858,885 TipRanks' Investors
Success Rate
23 out of 52
profitable transactions
profitable transactions
Average Return
17.54%
Average return
per transaction
per transaction
Share this portfolio:
Portfolio Gain
1-Month Return▲ 3.18%
6-Month Return▲ 1.39%
12-Month Return▲ 20.44%
YTD Return▲ 0.97%
Total Return▲ 35.02%
Best Trade
Bio
Long term investor
Performance
12.88%0-12.88%
▲ 12.88%
▲ 3.56%
▲ 4.89%
Sep 2025
▲ 10.96%
▲ 2.38%
▼ 1.55%
Oct 2025
▼ 3.68%
▲ 0.19%
▲ 1.63%
Nov 2025
▼ 0.10%
▲ 0.08%
▲ 0.13%
Dec 2025
▲ 4.06%
▲ 1.47%
▲ 4.06%
Jan 2026
▼ 1.12%
▼ 0.86%
▼ 0.26%
Feb 2026
▲ 0.60%
▼ 4.94%
▼ 7.64%
Mar 2026
▲ 4.89%
▲ 4.48%
▲ 5.33%
Apr 2026
▲ 12.88%▲ 3.56%▲ 4.89%
▲ 10.96%▲ 2.38%▼ 1.55%
▼ 3.68%▲ 0.19%▲ 1.63%
▼ 0.10%▲ 0.08%▲ 0.13%
▲ 4.06%▲ 1.47%▲ 4.06%
▼ 1.12%▼ 0.86%▼ 0.26%
▲ 0.60%▼ 4.94%▼ 7.64%
▲ 4.89%▲ 4.48%▲ 5.33%
Recent Activity
Novo Nordisk
1.79%
▼ 34.37%
2
Buy
Nov 24, 2025
Pfizer
1.47%
▼ 1.93%
2
Buy
Nov 15, 2025
Organon
0.6%
▼ 36.98%
3
Buy
Nov 15, 2025
Persimmon
1.94%
▼ 8.61%
3
Buy
Aug 23, 2025
Consolidated Comms
―
▼ 13.62%
4
Close
Dec 31, 2024
Unilever
―
▼ 1.90%
2
Close
Jan 27, 2024
Salesforce
5.63%
▼ 23.09%
3
Sell
Jan 25, 2024
SPDR Gold Shares
29.83%
▲ 149.74%
4
Buy
Dec 23, 2023
Hikma Pharmaceuticals
―
▼ 32.11%
3
Close
Dec 23, 2023
Hikma Pharmaceuticals
20.6%
▼ 7.36%
2
Buy
Dec 23, 2023
Unilever
1.76%
▼ 10.34%
2
Buy
Dec 23, 2023
Sandoz Group Ltd Sponsored ADR
0.58%
▲ 167.57%
1
Open
Dec 23, 2023
Krispy Kreme
―
▲ 14.04%
2
Close
May 13, 2022
Invesco DWA Technology Momentum ETF
―
▼ 13.84%
3
Close
Apr 25, 2022
Novartis
5.26%
▲ 117.99%
3
Buy
Mar 08, 2022
Gilead Sciences
―
▲ 4.21%
2
Close
Jan 22, 2022
TuSimple Holdings
―
▼ 41.52%
2
Close
Jan 22, 2022
GlaxoSmithKline
―
▼ 1.11%
2
Close
Jan 22, 2022
ARK Genomic Revolution ETF
0.91%
▼ 63.41%
2
Buy
Jan 04, 2022
Grayscale Digital Large Cap Fund LLC
0.68%
▲ 16.53%
3
Open
Oct 15, 2021